High-sensitivity cardiac troponin T 30 days all-come mortality in patients with acute heart failure. A Propensity Score-Matching Analysis Based on the EAHFE Registry. TROPICA4 Study
- PMID: 32306389
- DOI: 10.1111/eci.13248
High-sensitivity cardiac troponin T 30 days all-come mortality in patients with acute heart failure. A Propensity Score-Matching Analysis Based on the EAHFE Registry. TROPICA4 Study
Abstract
Background: Acute heart failure (AHF) patients with high troponin levels have a worse prognosis. High-sensitive troponin T (hs-TnT) has been used as a tool to stratify prognosis in many scales but always as a qualitative and not as a quantitative variable.
Objectives: The main objective of this study was to determine the best hs-TnT cut-off for prediction of 30-day all-cause mortality.
Methods: The EAHFE registry, a prospective follow-up cohort of patients with AHF, was analysed. We performed a propensity score analysis of the optimal hs-TnT cut-off point previously determined by receiver operating characteristic (ROC) curve analysis.
Results: Of the 13 791 patients in the EAHFE cohort, we analysed 3190 patients in whom hs-TnT determination was available. The area under the ROC curve for 30-day all-cause mortality was 0.70 (CI95% 0.68 to 0.71; P < .001), establishing an optimal cut-off of hs-TnT of 35 ng/L. The sensitivity and specificity of this cut-off were 76.2 and 55.5%, respectively, with a negative predictive value (NPV) of 95.3%. A propensity score was made with 34 variables showing differences based on the cut-off of 35 ng/L for hs-TnT. In the analysis of the population obtained with the propensity score, patients with hs-TnT > 35 ng/L showed a greater 30-day all-cause mortality, with a HR of 2.95 (CI95% 1.83-4.75; P < .001). External validation reported similar results.
Conclusions: An hs-TnT value of 35 ng/L is an adequate cut-off to evaluate the prediction of 30-day all-cause mortality with a NPV of 95.3%.
Keywords: 30-days mortality; acute heart failure; prognosis; troponin.
© 2020 Stichting European Society for Clinical Investigation Journal Foundation.
References
REFERENCES
-
- Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137-1146.
-
- Bleumink G, Knetsch A, Sturkenboom M et al Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J. 2004;25:1614-1619.
-
- Delgado JF, Oliva J, Llano M et al Health care and non-health care costs in the treatment of patients with symptomatic chronic heart failure in Spain. Rev EspCardiol. 2014;67:643-650.
-
- Llorens P, Javaloyes P, Martín-Sánchez FJ et al Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure. Clin R Cardiol. 2018;107:897-913.
-
- Llorens P. Risk assessment in emergency department patients with acute heart failure: We need to reach beyond our clinical judgment. Emergencias. 2018;30:75-76.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous